In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $6.42, marking a +1.58% move from the previous day. This move lagged the S&P 500's daily gain of 1.83%. On the other hand, the ...

Officials who oversee an international treaty governing endangered species recommended suspending shipments of long-tailed ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

Residents who returned to unburned homes after a 2021 wildfire near Boulder, Colorado often reported health issues months ...

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Ideas: AI and democracy with Madeleine Daepp and Robert Osazuwa Ness ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS – Research Report), Quanterix ...

Testing new antibiotics in India, South Africa or Brazil, where they are needed most, makes scientific sense. But it’s not ...

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Scientists have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, ...